{"id":"W1926944110","doi":"10.5603/cj.2015.0068","title":"Can ivabradine reduce NT-proBNP and improve outcomes in systolic heart failure?","year":2015,"lang":"en","type":"letter","venue":"Cardiology Journal","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ivabradine; Medicine; Cardiology; Internal medicine; Heart failure; Ejection fraction; Myocardial infarction; Clinical endpoint; Canadian Cardiovascular Society; Coronary artery disease; Heart rate; Blood pressure; Clinical trial; Angina","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002040013,0.0004907048,0.002872105,0.0005141059,0.0001248908,0.00004577862,0.0001634832,0.001568369,0.00002202416],"category_scores_gemma":[0.0003417929,0.0003797593,0.0007313907,0.000162461,0.000229012,0.00006655818,0.00008100035,0.005931616,0.00004549279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005597793,"about_ca_system_score_gemma":0.001679121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001210154,"about_ca_topic_score_gemma":0.00001684653,"domain_scores_codex":[0.9962272,0.0008873193,0.0007812642,0.0005833297,0.00053223,0.0009886714],"domain_scores_gemma":[0.9981705,0.000108113,0.0001898273,0.0006833032,0.0003111771,0.0005370641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003342561,0.000008974891,0.02017858,0.0002573151,0.0009057625,0.007938856,0.0001170733,0.000003859134,0.000236601,0.000003263309,0.9695134,0.000802894],"study_design_scores_gemma":[0.002654187,0.0004058186,0.01344774,0.0002477974,0.0005069436,0.08274197,0.0001400688,0.000003800508,0.00002277631,0.0002201213,0.8992445,0.0003642905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0890796,0.01015883,0.00002273364,0.8966863,0.002267955,0.0007743628,0.00005278438,0.00004841584,0.0009089797],"genre_scores_gemma":[0.1403548,0.002246959,0.0008790182,0.8143256,0.03696489,0.0001089048,0.0002775433,0.0002725814,0.00456973],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.08236075,"threshold_uncertainty_score":0.9998654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02636338362473249,"score_gpt":0.2944980103329606,"score_spread":0.2681346267082281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}